Enanta Pharmaceuticals Inc. buy Rodman & Renshaw
Start price
26.03.26
/
50%
€10.60
Target price
26.03.27
€17.30
Performance (%)
6.60%
Price
24.04.26
€11.30
Summary
This prediction is currently active. With a performance of 6.60%, the BUY prediction by Rodman___Renshaw for Enanta Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 26.03.27. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Enanta Pharmaceuticals Inc. | -4.237% |
| iShares Core DAX® | -1,74 % |
| iShares Nasdaq 100 | 2,81 % |
| iShares Nikkei 225® | -0,11 % |
| iShares S&P 500 | 0,97 % |
Comments by Rodman___Renshaw for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat